Socioeconomic deprivation in residential areas does not appear to influence blood-based markers of Alzheimer disease in older men over time.

Individuals with idiopathic intracranial hypertension exhibit distinct circulating lipid and amino acid profiles compared with those who have obesity.

Even among younger individuals with severe mental illness, there is an increased odds ratio for dementia and ischemic stroke.

A new algorithm appears to identify hypertension, ischemic heart disease, and cerebrovascular accidents during routine mammography.

Non-vitamin K oral anticoagulants are associated with modestly slower cognitive decline among patients with atrial fibrillation and Alzheimer disease.

The phase 3 Lp(a)HORIZON trial found that while pelacarsen lowered Lp(a) levels, it did not reduce major cardiovascular events in patients with established CVD.

An updated science advisory from the American Heart Association supports minimally invasive surgical evacuation for lobar intracerebral hemorrhage.

There is a trend of increasingly disproportionate autism spectrum disorder diagnoses among female patients after 2020.

Older adults with essential tremor have a higher burden of mild cognitive impairment and dementia than the general population.

The FDA approved Zanvastro (zilganersen), the first disease-modifying treatment for Alexander disease in pediatric and adult patients.

Quality of life and functional physical performance are positively associated among people with relapsing-remitting multiple sclerosis.

Following intracerebral hemorrhage, intensive BP lowering reduces risk for recurrent stroke without an increase in serious adverse events.